Bello I. O. Keratocystic odontogenic tumor: A biopsy service's experience with 104 solitary, multiple and recurrent lesions. Med Oral Patol Oral Cir Bucal. 2016; 21 (5): e538-46.
Zhao Y. F., Wei J. X., Wang S. P. Treatment of odontogenic keratocysts: a follow-up of 255 Chinese patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94 (2): 151-6.
Ribeiro-Junior O., Borba A. M., Alves C. A. F., Gouveia M. M., Deboni M. C. Z., Naclerio-Homem MDG. Reclassification and treatment of odontogenic keratocysts: A cohort study. Braz Oral Res. 2017; 31: e98.
Chrcanovic B. R., Gomez R. S. Recurrence probability for keratocystic odontogenic tumors: An analysis of 6427 cases. J Craniomaxillofac Surg. 2017; 45 (2): 244-51.
Gonzalez Galvan M del C., Garcia-Garcia A., Anitua-Aldecoa E., Martinez-Conde Llamosas R., Aguirre-Urizar J. M. Orthokeratinized odontogenic cyst: a report of three clinical cases. Case Rep Dent. 2013; 2013: 672383.
Johnson N. R., Batstone M. D., Savage N. W. Management and recurrence of keratocystic odontogenic tumor: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 116 (4): e271-6.
Parmar S., Al-Qamachi L., Aga H. Ameloblastomas of the mandible and maxilla. Curr Opin Otolaryngol Head Neck Surg. 2016; 24 (2): 148-54.
Faras F., Abo-Alhassan F., Israel Y., Hersant B., Meningaud J. P. Multi-recurrent invasive ameloblastoma: A surgical challenge. Int J Surg Case Rep. 2017; 30: 43-5.
Mendenhall W. M., Werning J. W., Fernandes R., Malyapa R. S., Mendenhall N. P. Ameloblastoma. Am J Clin Oncol. 2007; 30 (6): 645-8.
Nakamura N., Mitsuyasu T., Higuchi Y., Sandra F, Ohishi M. Growth characteristics of ameloblastoma involving the inferior alveolar nerve: a clinical and histopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91 (5): 557-62.
Grasmuck E. A., Nelson B. L. Keratocystic odontogenic tumor. Head Neck Pathol. 2010; 4 (1): 94-6.
Habibi A., Saghravanian N., Habibi M., Mellati E., Habibi M. Keratocystic odontogenic tumor: a 10-year retrospective study of 83 cases in an Iranian population. J Oral Sci. 2007; 49 (3): 229-35.
Soluk-Tekkesin M., Wright J. M. The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2017 (4th) Edition. Turk Patoloji Derg. 2018; 34 (1).
Wright J. M., Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017; 11 (1): 68-77.
Bataineh A. B., al Qudah M. Treatment of mandibular odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86 (1): 42-7.
Meara J. G., Shah S., Li K. K., Cunningham M. J. The odontogenic keratocyst: a 20-year clinicopathologic review. Laryngoscope. 1998; 108 (2): 280-3.
Ianculovici C., Blinder D., O Peleg. Trends in recurrence of keratocystic odontogenic tumor. Int J Oral Dent Health. 2016; 2 (3):1-4.
Myoung H., Hong S. P., Hong S. D., Lee J. I., Lim C. Y., Choung P. H., et al. Odontogenic keratocyst: Review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91 (3): 328-33.
Infante-Cossio P., Prats-Golczer V., Gonzalez-Perez L. M., Belmonte-Caro R., Martinez DEFR, Torres-Carranza E., et al. Treatment of recurrent mandibular ameloblastoma. Exp Ther Med. 2013; 6 (2): 579-83.
Figueiredo N. R., Dinkar A. D., Meena M., Satoskar S., Khorate M. Ameloblastoma: A clinicoradiographic and histopathologic correlation of 11 cases seen in Goa during 2008-2012. Contemp Clin Dent. 2014; 5 (2): 160-5.
Aramanadka C., Kamath A. T., Kudva A. Recurrent Ameloblastoma: A Surgical Challenge. Case Rep Dent. 2018; 2018: 8271205.
Carlson E. R., Marx R. E. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006; 64 (3): 484-94.
Ackermann G. L., Altini M., Shear M. The unicystic ameloblastoma: a clinicopathological study of 57 cases. J Oral Pathol. 1988; 17 (9-10): 541-6.
Nakamura N., Higuchi Y., Mitsuyasu T., Sandra F., Ohishi M. Comparison of long-term results between different approaches to ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93 (1): 13-20.
Sampson D. E., Pogrel M. A. Management of mandibular ameloblastoma: the clinical basis for a treatment algorithm. J Oral Maxillofac Surg. 1999; 57 (9): 1074-7; discussion 8-9.
Hong J., Yun P. Y., Chung I. H., Myoung H., Suh J. D., Seo B. M., et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg. 2007; 36 (4): 283-8.
Mortazavi H., Baharvand M. Jaw lesions associated with impacted tooth: A radiographic diagnostic guide. Imaging Sci Dent. 2016; 46 (3): 147-57.
Crowley T. E., Kaugars G. E., Gunsolley J. C. Odontogenic keratocysts: a clinical and histologic comparison of the parakeratin and orthokeratin variants. J Oral Maxillofac Surg. 1992; 50 (1): 22-6.
Milman T., Lee V., LiVolsi V. Maxillary Ameloblastoma with Orbital Involvement: An Institutional Experience and Literature Review. Ophthalmic Plast Reconstr Surg. 2016;32(6):441-6.
- Abstract viewed - 733 times
- PDF downloaded - 292 times
- HTML downloaded - 330 times
- EPUB downloaded - 82 times
© , 2020
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Karadeniz Teknik University, Trabzon, Turkey.
Zeynep Sagnak Yilmaz
Department of Pathology, Kanuni Training and Research Hospital, Trabzon, Turkey.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Recep Tayyip Erdogan University, Rize, Turkey.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Saglık Bilimleri University, Istanbul, Turkey.
How to Cite
Management of Recurrence of Ameloblastoma and Odontogenic Keratocyst: A Cross-Sectional Study
Vol 22 No 3 (2020): Odovtos-International Journal of Dental Sciences
Published: Apr 27, 2020
Objectives: Odontogenic keratocyst (OKC) and ameloblastoma are slowly growing and locally invasive tumors with high recurrence rate. The aim of this study was to investigate the clinicopathologic features of recurrent ameloblastoma and OKC cases, and evaluate outcomes of our treatments in terms of recurrence. Material and Methods: A total of 23 patients with confirmed recurrent ameloblastoma or OKC and treated in our clinic within eleven years period were reviewed retrospectively. Results: Eleven recurrent OKC cases and twelve recurrent ameloblastoma cases were included. Most recurrences occurred within five years after the initial treatment (69.6%). Enucleation had the highest recurrence rate among the first treatments (18/23). All recurrences were located in the mandible, with one exception (22/23). All recurrent OKCs were multilocular. Different histopathologic subtypes of ameloblastoma were seen in our study, follicular ameloblastoma was the most common (8/12). The mean diameter of the lesions was 4.3 cm (ranging from 2 cm to 7 cm). Statically significant relation was found between location and diameter of lesion and year of recurrence onset (p=0.004; p=0.026). We performed radical treatments in these cases (ten patients underwent marginal resections, and thirteen patients underwent segmental resection), and no recurrence was observed during the follow-up period. Conclusion: Previous inadequate surgical procedures were the most important cause of recurrence. Marginal or segmental resection with safety margins is the best method to treat recurrences of OKC or ameloblastoma cases.